Analysis of serum cross-reactivity and cross-protection elicited by immunization with DNA vaccines against Streptococcus pneumoniae expressing PspA fragments from different clades.
Infect Immun.
2002 Sep;70(9):5086-90. doi: 10.1128/IAI.70.9.5086-5090.2002. PubMed PMID:
12183557; PubMed Central PMCID:
PMC128265.
DNA vaccines based on genetically detoxified derivatives of pneumolysin fail to protect mice against challenge with Streptococcus pneumoniae.
FEMS Immunol Med Microbiol.
2006 Mar;46(2):291-7. doi: 10.1111/j.1574-695X.2006.00040.x. PubMed PMID:
16487311.
DNA vaccines expressing pneumococcal surface protein A (PspA) elicit protection levels comparable to recombinant protein.
J Med Microbiol.
2006 Apr;55(Pt 4):375-378. doi: 10.1099/jmm.0.46217-0. PubMed PMID:
16533983.
Fusion proteins containing family 1 and family 2 PspA fragments elicit protection against Streptococcus pneumoniae that correlates with antibody-mediated enhancement of complement deposition.
Infect Immun.
2007 Dec;75(12):5930-8. doi: 10.1128/IAI.00940-07. Epub 2007 Oct 8. PubMed PMID:
17923518; PubMed Central PMCID:
PMC2168346.
Optimized immune response elicited by a DNA vaccine expressing pneumococcal surface protein a is characterized by a balanced immunoglobulin G1 (IgG1)/IgG2a ratio and proinflammatory cytokine production.
Clin Vaccine Immunol.
2008 Mar;15(3):499-505. doi: 10.1128/CVI.00400-07. Epub 2008 Jan 9. PubMed PMID:
18184825; PubMed Central PMCID:
PMC2268278.
Nasal immunization of mice with Lactobacillus casei expressing the Pneumococcal Surface Protein A: induction of antibodies, complement deposition and partial protection against Streptococcus pneumoniae challenge.
Microbes Infect.
2008 Apr;10(5):481-8. doi: 10.1016/j.micinf.2008.01.007. Epub 2008 Jan 20. PubMed PMID:
18403234.
Recognition of pneumococcal isolates by antisera raised against PspA fragments from different clades.
J Med Microbiol.
2008 Mar;57(Pt 3):273-278. doi: 10.1099/jmm.0.47661-0. PubMed PMID:
18287288.
Characterization of protective mucosal and systemic immune responses elicited by pneumococcal surface protein PspA and PspC nasal vaccines against a respiratory pneumococcal challenge in mice.
Clin Vaccine Immunol.
2009 May;16(5):636-45. doi: 10.1128/CVI.00395-08. Epub 2009 Mar 11. PubMed PMID:
19279169; PubMed Central PMCID:
PMC2681601.
Comparison of the pulmonary response against lethal and non-lethal intranasal challenges with two different pneumococcal strains.
Microb Pathog.
2009 Sep;47(3):157-63. doi: 10.1016/j.micpath.2009.05.005. Epub 2009 May 23. PubMed PMID:
19467320.
The immunising effect of pneumococcal nasopharyngeal colonisation; protection against future colonisation and fatal invasive disease.
Immunobiology.
2010 Apr;215(4):251-63. doi: 10.1016/j.imbio.2009.12.004. Epub 2009 Dec 28. PubMed PMID:
20071053.
Immunization of mice with single PspA fragments induces antibodies capable of mediating complement deposition on different pneumococcal strains and cross-protection.
Clin Vaccine Immunol.
2010 Mar;17(3):439-46. doi: 10.1128/CVI.00430-09. Epub 2010 Jan 20. PubMed PMID:
20089795; PubMed Central PMCID:
PMC2837969.
Protection against nasal colonization with Streptococcus pneumoniae by parenteral immunization with a DNA vaccine encoding PspA (Pneumococcal surface protein A).
Microb Pathog.
2010 Jun;48(6):205-13. doi: 10.1016/j.micpath.2010.02.009. Epub 2010 Mar 4. PubMed PMID:
20206678.
Combination of pneumococcal surface protein A (PspA) with whole cell pertussis vaccine increases protection against pneumococcal challenge in mice.
PLoS One.
2010 May 27;5(5):e10863. doi: 10.1371/journal.pone.0010863. PubMed PMID:
20523738; PubMed Central PMCID:
PMC2877721.
Pneumolysin activates the NLRP3 inflammasome and promotes proinflammatory cytokines independently of TLR4.
PLoS Pathog.
2010 Nov 11;6(11):e1001191. doi: 10.1371/journal.ppat.1001191. PubMed PMID:
21085613; PubMed Central PMCID:
PMC2978728.
Nasal immunization of mice with Lactobacillus casei expressing the pneumococcal surface protein C primes the immune system and decreases pneumococcal nasopharyngeal colonization in mice.
FEMS Immunol Med Microbiol.
2011 Aug;62(3):263-72. doi: 10.1111/j.1574-695X.2011.00809.x. Epub 2011 May 9. PubMed PMID:
21492260.
Experimental human pneumococcal carriage models for vaccine research.
Trends Microbiol.
2011 Sep;19(9):464-70. doi: 10.1016/j.tim.2011.06.003. Epub 2011 Jul 23. Review. PubMed PMID:
21784641.
Elicitation of mucosal immunity by proteins of Streptococcus pneumoniae.
Adv Otorhinolaryngol.
2011;72:25-7. doi: 10.1159/000324589. Epub 2011 Aug 18. PubMed PMID:
21865682.
Cross-reactivity of antipneumococcal surface protein C (PspC) antibodies with different strains and evaluation of inhibition of human complement factor H and secretory IgA binding via PspC.
Clin Vaccine Immunol.
2012 Apr;19(4):499-507. doi: 10.1128/CVI.05706-11. Epub 2012 Feb 15. PubMed PMID:
22336290; PubMed Central PMCID:
PMC3318277.
Human nasal challenge with Streptococcus pneumoniae is immunising in the absence of carriage.
PLoS Pathog.
2012;8(4):e1002622. doi: 10.1371/journal.ppat.1002622. Epub 2012 Apr 5. PubMed PMID:
22496648; PubMed Central PMCID:
PMC3320601.
T regulatory cells control susceptibility to invasive pneumococcal pneumonia in mice.
PLoS Pathog.
2012;8(4):e1002660. doi: 10.1371/journal.ppat.1002660. Epub 2012 Apr 19. PubMed PMID:
22563306; PubMed Central PMCID:
PMC3334885.
Controlled inflammatory responses in the lungs are associated with protection elicited by a pneumococcal surface protein A-based vaccine against a lethal respiratory challenge with Streptococcus pneumoniae in mice.
Clin Vaccine Immunol.
2012 Sep;19(9):1382-92. doi: 10.1128/CVI.00171-12. Epub 2012 Jul 3. PubMed PMID:
22761301; PubMed Central PMCID:
PMC3428385.
Characterization of the antibody response elicited by immunization with pneumococcal surface protein A (PspA) as recombinant protein or DNA vaccine and analysis of protection against an intranasal lethal challenge with Streptococcus pneumoniae.
Microb Pathog.
2012 Nov-Dec;53(5-6):243-9. doi: 10.1016/j.micpath.2012.08.007. Epub 2012 Sep 7. PubMed PMID:
22981893.
Experimental human pneumococcal carriage.
J Vis Exp.
2013 Feb 15;(72). doi: 10.3791/50115. PubMed PMID:
23439027; PubMed Central PMCID:
PMC3601207.
Experimental human pneumococcal carriage augments IL-17A-dependent T-cell defence of the lung.
PLoS Pathog.
2013 Mar;9(3):e1003274. doi: 10.1371/journal.ppat.1003274. Epub 2013 Mar 28. PubMed PMID:
23555269; PubMed Central PMCID:
PMC3610738.
Controlled human infection and rechallenge with Streptococcus pneumoniae reveals the protective efficacy of carriage in healthy adults.
Am J Respir Crit Care Med.
2013 Apr 15;187(8):855-64. doi: 10.1164/rccm.201212-2277OC. PubMed PMID:
23370916; PubMed Central PMCID:
PMC3707375.
Increased IgG but normal IgA anti-pneumococcal protein antibodies in lung of HIV-infected adults.
Vaccine.
2013 Aug 2;31(35):3469-72. doi: 10.1016/j.vaccine.2013.04.062. Epub 2013 May 10. PubMed PMID:
23664995; PubMed Central PMCID:
PMC3740234.
Mapping of epitopes recognized by antibodies induced by immunization of mice with PspA and PspC.
Clin Vaccine Immunol.
2014 Jul;21(7):940-8. doi: 10.1128/CVI.00239-14. Epub 2014 May 7. PubMed PMID:
24807052; PubMed Central PMCID:
PMC4097434.
Density and duration of experimental human pneumococcal carriage.
Clin Microbiol Infect.
2014 Dec;20(12):O1145-51. doi: 10.1111/1469-0691.12752. Epub 2014 Aug 11. PubMed PMID:
24995531; PubMed Central PMCID:
PMC4313687.
Detection of high levels of anti-α-galactosyl antibodies in sera of patients with Old World cutaneous leishmaniasis: a possible tool for diagnosis and biomarker for cure in an elimination setting.
Parasitology.
2014 Dec;141(14):1898-903. doi: 10.1017/S0031182014001607. Epub 2014 Oct 9. PubMed PMID:
25297927.
The adult nasopharyngeal microbiome as a determinant of pneumococcal acquisition.
Microbiome.
2014;2:44. doi: 10.1186/2049-2618-2-44. eCollection 2014. PubMed PMID:
25671106; PubMed Central PMCID:
PMC4323220.
Modulation of nasopharyngeal innate defenses by viral coinfection predisposes individuals to experimental pneumococcal carriage.
Mucosal Immunol.
2016 Jan;9(1):56-67. doi: 10.1038/mi.2015.35. Epub 2015 Apr 29. PubMed PMID:
25921341; PubMed Central PMCID:
PMC4703943.
Pulmonary dry powder vaccine of pneumococcal antigen loaded nanoparticles.
Int J Pharm.
2015 Nov 30;495(2):903-12. doi: 10.1016/j.ijpharm.2015.09.034. Epub 2015 Sep 18. PubMed PMID:
26387622.
First human challenge testing of a pneumococcal vaccine. Double-blind randomized controlled trial.
Am J Respir Crit Care Med.
2015 Oct 1;192(7):853-8. doi: 10.1164/rccm.201503-0542OC. PubMed PMID:
26114410.
Pneumococcal Colonization Rates in Patients Admitted to a United Kingdom Hospital with Lower Respiratory Tract Infection: a Prospective Case-Control Study.
J Clin Microbiol.
2016 Apr;54(4):944-9. doi: 10.1128/JCM.02008-15. Epub 2016 Jan 20. PubMed PMID:
26791364; PubMed Central PMCID:
PMC4809940.
Oral Typhoid Vaccination With Live-Attenuated Salmonella Typhi Strain Ty21a Generates Ty21a-Responsive and Heterologous Influenza Virus-Responsive CD4+ and CD8+ T Cells at the Human Intestinal Mucosa.
J Infect Dis.
2016 Jun 1;213(11):1809-19. doi: 10.1093/infdis/jiw030. Epub 2016 Jan 24. PubMed PMID:
26810369; PubMed Central PMCID:
PMC4857474.
When Do Coughs and Sneezes Cause Diseases?.
Am J Respir Crit Care Med.
2016 Jun 15;193(12):1329-30. doi: 10.1164/rccm.201601-0130ED. PubMed PMID:
27304239.
Agglutination by anti-capsular polysaccharide antibody is associated with protection against experimental human pneumococcal carriage.
Mucosal Immunol.
2017 Mar;10(2):385-394. doi: 10.1038/mi.2016.71. Epub 2016 Aug 31. PubMed PMID:
27579859; PubMed Central PMCID:
PMC5332540.
Neuraminidase A-Exposed Galactose Promotes Streptococcus pneumoniae Biofilm Formation during Colonization.
Infect Immun.
2016 Oct;84(10):2922-32. doi: 10.1128/IAI.00277-16. Print 2016 Oct. PubMed PMID:
27481242; PubMed Central PMCID:
PMC5038079.
Augmented Passive Immunotherapy with P4 Peptide Improves Phagocyte Activity in Severe Sepsis.
Shock.
2016 Dec;46(6):635-641. doi: 10.1097/SHK.0000000000000715. PubMed PMID:
27488089.
Polysaccharide-Specific Memory B Cells Predict Protection against Experimental Human Pneumococcal Carriage.
Am J Respir Crit Care Med.
2016 Dec 15;194(12):1523-1531. doi: 10.1164/rccm.201512-2467OC. PubMed PMID:
27403678; PubMed Central PMCID:
PMC5215029.
Novel Analysis of Immune Cells from Nasal Microbiopsy Demonstrates Reliable, Reproducible Data for Immune Populations, and Superior Cytokine Detection Compared to Nasal Wash.
PLoS One.
2017;12(1):e0169805. doi: 10.1371/journal.pone.0169805. eCollection 2017. PubMed PMID:
28107457; PubMed Central PMCID:
PMC5249128.
Single use and conventional bronchoscopes for Broncho alveolar lavage (BAL) in research: a comparative study (NCT 02515591).
BMC Pulm Med.
2017 May 5;17(1):83. doi: 10.1186/s12890-017-0421-7. PubMed PMID:
28476111; PubMed Central PMCID:
PMC5420119.
Pneumococcal Capsular Polysaccharide Immunity in the Elderly.
Clin Vaccine Immunol.
2017 Jun;24(6). doi: 10.1128/CVI.00004-17. Print 2017 Jun. Review. PubMed PMID:
28424198; PubMed Central PMCID:
PMC5461380.
A framework for Controlled Human Infection Model (CHIM) studies in Malawi: Report of a Wellcome Trust workshop on CHIM in Low Income Countries held in Blantyre, Malawi.
Wellcome Open Res.
2017;2:70. doi: 10.12688/wellcomeopenres.12256.1. eCollection 2017. PubMed PMID:
29018841; PubMed Central PMCID:
PMC5627502.
Assessing the ideal microwave duration for disinfection of sinus irrigation bottles-A quantitative study.
Clin Otolaryngol.
2018 Feb;43(1):261-266. doi: 10.1111/coa.12956. Epub 2017 Sep 14. PubMed PMID:
28815972.
Alveolar T-helper 17 responses to streptococcus pneumoniae are preserved in ART-untreated and treated HIV-infected Malawian adults.
J Infect.
2018 Feb;76(2):168-176. doi: 10.1016/j.jinf.2017.10.013. Epub 2017 Nov 29. PubMed PMID:
29197600; PubMed Central PMCID:
PMC5792245.
The immunological mechanisms that control pneumococcal carriage.
PLoS Pathog.
2017 Dec;13(12):e1006665. doi: 10.1371/journal.ppat.1006665. eCollection 2017 Dec. Review. PubMed PMID:
29267378; PubMed Central PMCID:
PMC5739485.
Mucosal immunization with PspA (Pneumococcal surface protein A)-adsorbed nanoparticles targeting the lungs for protection against pneumococcal infection.
PLoS One.
2018;13(1):e0191692. doi: 10.1371/journal.pone.0191692. eCollection 2018. PubMed PMID:
29360883; PubMed Central PMCID:
PMC5779684.
Antibodies Reactive to Commensal Streptococcus mitis Show Cross-Reactivity With Virulent Streptococcus pneumoniae Serotypes.
Front Immunol.
2018;9:747. doi: 10.3389/fimmu.2018.00747. eCollection 2018. PubMed PMID:
29713324; PubMed Central PMCID:
PMC5911667.
Human alveolar macrophages predominately express combined classical M1 and M2 surface markers in steady state.
Respir Res.
2018 Apr 18;19(1):66. doi: 10.1186/s12931-018-0777-0. PubMed PMID:
29669565; PubMed Central PMCID:
PMC5907303.
What would you like to do?